HCA Healthcare, Inc.: Form 10-K for the period ended Dec 31, 2015
Filed with the SEC on Feb 26, 2016 and accepted by EDGAR at Feb 26, 2016, 16:56 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 12 months2015-01-01 to 2015-12-31 | $1.67bn | us-gaap:InterestExpense |
| Income tax | 12 months2015-01-01 to 2015-12-31 | $1.26bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2015-10-01 to 2015-12-31 | $582.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2015-01-01 to 2015-12-31 | $2.13bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-10-01 to 2015-12-31 | $1.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2015-01-01 to 2015-12-31 | $4.99 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-10-01 to 2015-12-31 | $1.44 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2015-01-01 to 2015-12-31 | $5.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2015-01-01 to 2015-12-31 | 426,721,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2015-01-01 to 2015-12-31 | $4.73bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2015-01-01 to 2015-12-31 | $2.38bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2015-01-01 to 2015-12-31 | $2.40bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-12-31 | $741.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-12-31 | $9.23bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-12-31 | $32.74bn | us-gaap:Assets |
| Current liabilities | At period end2015-12-31 | $5.52bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-12-31 | $38.79bn | us-gaap:Liabilities |
| Long-term debt | At period end2015-12-31 | $30.25bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2015-12-31 | $233.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2015-12-31 | −$7.60bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-16-482165. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.